Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors

Human Pathology

Volumn 28, Issue 2, 1997, Pages 160-165

  Carrillo, Rosario ^a   Candia, Antonio ^b   Rodriguez Peralto, Jose L ^b   Caz, Victor ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NONE

Author keywords

DNA ploidy; gastrointestinal stromal tumor; image cytometry; prognosis; proliferation

Indexed keywords

DNA; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; PLOIDY; PROGNOSIS; TUMOR NECROSIS; TUMOR VOLUME;

EID: 0031015032     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90100-3     Document Type: Article

References (56)

1. Appelman HD: Smooth muscle tumors of the gastrointestinal tract: What we know now that Stout didn't know. Am J Surg Pathol 10:83-99, 1986 (suppl 1)
2. Evans HL: Smooth muscle tumors of the gastrointestinal tract: A study of 56 cases followed for a minimum of 10 years. Cancer 56:2242-2250, 1985
3. Kimura H, Yonemura Y, Kadoya N, et al: Prognostic factors in primary gastrointestinal leiomyosarcoma: A restrospective study. World J Surg 15:771-777, 1991
4. Seremetis MG, Lyons WS, De Guzman VC, et al: Leiomyomata of the esophagus: An analysis of 838 cases. Cancer 38:2166-2177, 1976
5. Ueyama T, Guo K, Hashimoto H, et al: A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 69:947-955, 1992
6. Akwari OE, Dozois RR, Weiland LH, et al: Leiomyosarcoma of the small and large bowel. Cancer 42:1375-1384, 1978
7. Appelman HD, Helwig EB: Gastric epithelioid leiomyoma and leiomyosarcoma. Cancer 138:708-728, 1976
8. Byard RW, Barr JR, Naidoo SP, et al: Gastric stromal tumors with epithelioid features: Clinicopathological features of 22 cases. Surg Pathol 3:281-288, 1990
9. Cooper PN, Quirke BM, Hardy GJ, et al: A flow cytometric, clinical and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol 16:163-170, 1992
10. Farrugia G, Chung H Kim, Grant CS, et al: Leiomyosarcoma of the stomach: Determinants of long-term survival. Mayo Clin Proc 67:533-536, 1992
11. Haque S, Dean PJ: Stromal neoplasms of the rectum and anal canal. HUM PATHOL 23:762-767, 1992
12. Lerma E, Oliva E, Tugués D, et al: Stromal tumors of the gastrointestinal tract: A clinicopathological and ploidy analysis of 33 cases. Virchows Arch 424:19-24, 1994
13. McGrath PC, Neifeld JP, Lawrence W, et al: Gastrointestinal sarcomas: Analysis of prognostic factors. Ann Surg 206:706-710, 1987
14. Ranchod M, Kempson RL: Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: A pathologic analysis of 100 cases. Cancer 39:255-262, 1977
15. Shiu MH, Farr GH, Papachristou DN, et al: Myosarcomas of the stomach: Natural history, prognostic factors and management. Cancer 49:177-187, 1982
16. Goldblum JR, Appelman HD: Stromal tumors of the duodenum: A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 19:71-80, 1995
17. Newman PL, Wadden C, Fletcher CDM: Gastrointestinal stromal tumours: Correlation of immunophenotype with clinicopathological features. J Pathol 164:107-117, 1991
18. Yu CC-W, Fletcher CDM, Newman PL, et al: A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol 166:147-152, 1992
19. Franquemont DW, Frierson HF Jr: Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors. Am J Clin Pathol 16:947-954, 1992
20. Appelman HD, Helwig EB: Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med 101:373-377, 1977
21. Lindsay PC, Ordoñez N, Raaf JH: Gastric leiomyosarcoma: Clinical and pathological review of fifty patients. J Surg Oncol 18:399-421, 1981
22. Morgan BK, Compton C, Talbert M, et al: Benign smooth muscle tumors of the gastrointestinal tract: A 24-year experience. Ann Surg 211:63-66, 1990
23. Herrera GA, Crezo L, Jones LE, et al: Gastrointestinal autonomic nerve tumors: "Plexosarcomas.§ Arch Pathol Lab Med 113:846-853, 1989
24. Cunningham RE, Federspiel BH, McCarthy WF, et al: Predicting prognosis of gastrointestinal smooth muscle tumors: Role of clinical and histological evaluation, flow cytometry, and image cytometry. Am J Surg Pathol 17:588-594, 1993
25. Franquemont DW: Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 103:41-47, 1995
26. D'Agnano I, D'Angelo C, Savarese A, et al: DNA ploidy, proliferative index, and epidermal growth factor receptor: Expression and prognosis in patients with gastric cancers. Lab Invest 72:432-438, 1995
27. Ellis CN, Burnette JJ, Sedlak R, et al: Prognostic applications of DNA analysis in solid malignant lesions in humans. Surg Gynecol Obstet 173:329-342, 1991
28. Pence JC, Kerns BJ, Dodge RK, et al: Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. Arch Surg 128:1382-1390, 1993
29. Veronese SM, Gambacorta M, Gottardi O, et al: Proliferation index as a prognostic marker in breast cancer. Cancer 71:3926-3931, 1993
30. Amin MB, Chan K MA, Linden MD, et al: Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors: Correlation with mitotic count and clinical outcome. Am J Clin Pathol 100:428-432, 1993
31. EI-Naggar AK, Ro JY, McLemore D, et al: Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least five years of follow-up. Mod Pathol 2:511-515, 1989
32. Franquemont DW, Frierson HF: Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod Pathol 8:473-477, 1995
33. Sbaschnig RJ, Cunningham RE, Sobin LH, et al: Proliferating-cell nuclear antigen immunohistochemistry in the evaluation of gastrointestinal smooth-muscle tumors. Mod Pathol 7:780-783, 1994
34. Federspiel HB, Sobin LH, Helwig EB, et al: Morphometry and cytophotometric assessment of DNA in smooth muscle tumors (leiomyomas and leiomyosarcomas) of the gastrointestinal tract. Anal Quant Cytol Histol 9:105-114, 1987
35. Tsushima K, Rainwater LM, Goellner JR, et al: Leiomyosarcomas and benign smooth muscle tumors of the stomach: Nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 62:275-280, 1987
36. Kimura O, Kaibara N, Tamura H, et al: Comparative study on the nuclear DNA content of leiomyoma, leiomyoblastoma, and leiomyosarcoma of the stomach and small intestine. Jpn J Surg 11:428-432, 1981
37. Kiyabu MT, Bishop PC, Parker JW, et al: Smooth muscle tumors of the gastrointestinal tract: Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade. Am J Surg Pathol 12:954-960, 1988
38. Tsushima K, Stanhope CR, Gaffey TA, et al: Uterine leiomyosarcomas and benign smooth muscle tumors: Usefulness of nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 63:248-255, 1988
39. Lerma E, Lee SJ, Tugués D, et al: Ploidy of 36 stromal tumors of the gastrointestinal tract: A comparative study with flow cytometry and image analysis. Anal Quant Cytol Histol 16:435-440, 1994
40. Shimamoto T, Haruma K, Sumii K, et al: Flow cytometric DNA analysis of gastric smooth muscle tumors. Cancer 70:2031-2034, 1992
41. Suzuki H, Sugihira H: Prognostic value of DNA ploidy in primary gastric leiomyosarcoma. Br J Surg 80:1549-1550, 1993
42. Ray R, Tahan SR, Andrews C, et al: Stromal tumors of the stomach: Prognostic value of the PCNA index. Mod Pathol 7:26-30, 1994
43. Yuki M, Yokota K, Okuyama S: Cell proliferation and cell death (apoptosis) as indices differentiating malignant from benign gastrointestinal myogenic tumors. Nippon Shokakibyo Gakkai Zasshi 92:206-216, 1995
44. Hedley DW, Friendlander ML, Taylor IW: Application of DNA flow cytometry to paraffin embedded archival material for the study of aneupoidy and its clinical significance. Cytometry 6:327-333, 1985
45. Leader MB, Kay EW, CJB Walsh, et al: Assessment of DNA ploidy: A review of methods and significance. Curr Diagn Pathol 1:105-113, 1994
46. Silverberg SG: Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus. HUM PATHOL 7:451-454, 1976
47. Simpson JF, Dutt PL, Page DL: Expression of mitoses per thousand cells and cell density in breast carcinomas: A proposal. HUM PATHOL 23:608-611, 1992
48. van Diest PJ, Baak JPA, Matze-Cok P, et al: Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project. HUM PATHOL 23:603-607, 1992
49. Bedikian AY, Khankhanian N, Valdivieso M, et al: Sarcoma of the stomach: Clinicopathologic study of 43 cases. J Surg Oncol 13:121-127, 1980
50. Flint A, Appelman HD, Beckwith AL: DNA analysis of gastric stromal neoplasms: Correlation with pathologic features. Surg Pathol 2:117-124, 1989
51. Dorman A, Graham D, Curran B, et al: Ploidy of smooth muscle tumours: Retrospective image anlysis study of formalin fixed, paraffin wax embedded tissue. J Clin Pathol 43:465-468, 1990
52. Peters III WA, Howard DR, Andersen WA, et al: Deoxyribo-nucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potencial. Am J Obstet Gynecol 166:1646-1654, 1992
53. Franquemont DW, Geary WA: Gastrointestinal stromal tumors and proliferating cell nuclear antigen: Prognostic challenges. Am J Surg Pathol 100:369-370, 1993
54. Hiruki T, Wolber RA, Owen DA: Proliferating cell nuclear antigen is not a useful prognostic indicator for gastrointestinal stromal tumors. Mod Pathol 6:47A, 1993 (abstr)
55. Rose DSC, Maddox PH, Brown DC: Which proliferation marker for routine immunohistology? A comparison of five antibodies. J Clin Pathol 47:1010-1014, 1994
56. Keshgegian AA, Cnaan A: Proliferation markers in breast carcinoma: Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am J Clin Pathol 104:42-49, 1995